Regeneron Pharmaceuticals, Inc.
Antibodies comprising chimeric constant domains

Last updated:

Abstract:

Antibodies, antigen-binding proteins and Fc-fusion proteins that comprise recombinant polypeptides containing a chimeric heavy chain constant region sequence are provided that bind to certain Fc receptors however have reduced effector functions. Methods of making constructs for expression of such chimeric Fc-containing antibodies, antigen-binding proteins and Fc-fusion proteins in cell systems, and methods of producing and isolating the chimeric Fc-containing proteins are provided.

Status:
Grant
Type:

Utility

Filling date:

12 Sep 2018

Issue date:

27 Apr 2021